sábado, 20 de setembro de 2008

Doctor's Guide, Setembro, 19

FDA: Fatal Case of Progressive Multifocal Leukoencephalopathy in Patient Receiving Rituximab
ROCKVILLE, Md -- September 11, 2008 -- The US Food and Drug Administration (FDA) and Genentech are notifying healthcare professionals of revisions to prescribing information for rituximab (Rituxan) regarding a case of progressive multifocal leukoencephalopathy (PML) leading to death in a patient with rheumatoid arthritis (RA) who received ...Full Story





Most read General Medicine news in the past 7 days

Papers and articles, pertaining to General Medicine, most read by your colleagues in the past 7 days

More news...

In the past 7 days, 251 papers and articles pertaining to General Medicine were added to the DG database. For a full list click here.

Nenhum comentário: